AstraZeneca new tablet formulation of Calquence gets USFDA okay Ruchika Sharma8 Aug 2022 12:30 PM IST"The tablet can be taken with gastric acid-reducing agents, including proton pump inhibitors (PPIs), antacids and H2-receptor antagonists (H2RAs),"...
Cipla betting big on emerging segments to drive its next phase of growth Ruchika Sharma8 Aug 2022 11:34 AM IST"Going forward all our growth engines will be fueled by our digital transformation initiatives," Cipla Managing Director and Global CEO Umang Vohra...
Govt informs gap between 2nd dose, precaution dose of COVID vaccines reduced on NTAGI recommendation Ruchika Sharma7 Aug 2022 3:15 PM ISTNew Delhi: Based on the recommendations made by the National Technical Advisory Group on Immunisation (NTAGI), the interval between the second and the...
Amgen to acquire ChemoCentryx for USD 4 billion in cash Ruchika Sharma7 Aug 2022 2:15 PM ISTThousand Oaks: Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune...
Arbitration ruling over BASF claims is imminent: Bayer Ruchika Sharma7 Aug 2022 1:30 PM ISTFrankfurt: Bayer's chief executive said an arbitration court would soon decide on claims brought by rival BASF, saying it overpaid for assets...
Sanofi, Innovent Biologics ink pact to accelerate development of oncology medicines in China Ruchika Sharma7 Aug 2022 12:30 PM ISTIn addition to the collaboration and license agreement, Sanofi will invest €300 million in Innovent through subscription of new common shares.
Pfizer, Myovant Sciences get USFDA nod for MYFEMBREE Ruchika Sharma7 Aug 2022 11:30 AM ISTMYFEMBREE offers an effective, once-daily treatment option for the management of moderate to severe pain associated with endometriosis, with a...
Cipla EU to acquire additional 19.16 percent stake in Cipla Maroc Ruchika Sharma6 Aug 2022 5:15 PM ISTNew Delhi: Cipla (EU) Limited, wholly owned subsidiary of the Company in UK, has agreed to acquire an additional 19.16% stake in Cipla Maroc SA, ...
AstraZeneca Enhertu secures USFDA nod for HER2-low breast cancer Ruchika Sharma6 Aug 2022 2:30 PM ISTEnhertu is a HER2-directed ADC.
Bharat Biotech says Japan approves Covaxin booster dose for travellers Ruchika Sharma6 Aug 2022 1:30 PM ISTNew Delhi: Bharat Biotech has announced that Japan has approved Covaxin booster dosage for travellers visiting the country. In a tweet, Bharat Biotech...
Biocon Biologics Malaysian arm enters Malaysia Book of Records Ruchika Sharma6 Aug 2022 12:15 PM ISTBiocon Biologics has created a Center of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to manufacture a broad portfolio of...
Zydus Ahmedabad facility gets 4 USFDA observations Ruchika Sharma6 Aug 2022 11:26 AM ISTAhmedabad: Zydus Lifesciences has recently announced that the US Food and Drug Administration (USFDA) has issued four observations after the...
